Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis

Journal of Infectious Diseases

Volumn 176, Issue 2, 1997, Pages 478-484

  Friedman, Cindy R ^b   Quinn, Geoff C ^c   Kreiswirth, Barry N ^c   Perlman, David C ^c   Salomon, Nadim ^c   Schluger, Neil ^c   Lutfey, Michael ^c   Berger, Judith ^c   Poltoratskaia, Natasha ^c   Riley, W Lee ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 16944362074     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514067     Document Type: Article

References (32)

1. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995;333:229-33.
2. Bureau of Tuberculosis Control. Information summary. New York: New York City Department of Health, 1994.
3. Friedman CR, Stoeckle MY, Kreiswirth BN, et al. Transmission of multidrug-resistant tuberculosis in a large urban setting. Am J Respir Crit Care Med 1995;152:355-9.
4. Casper C, Singh SP, Rane S, et al. Transcontinental transmission of tuberculosis? A molecular epidemiological assessment. Am J Public Health 1996;86:551-3.
5. O'Brien L, Carmichael J, Lowrie DB, Andrew PW. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect Immun 1994;62:5187-90.
6. Nicholson S, Bonecini-Almeida MG, Silva JRL, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;183:2293-302.
7. van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9. Comments in J Clin Microbiol 1993;31:1959, 2834-5.
8. van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9. Comments in J Clin Microbiol 1993;31:1959, 2834-5.
9. Plikaytis BB, Marden JL, Crawford JT, et al. Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J Clin Microbiol 1994;32:1542-6.
10. Ross BC, Raios K, Jackson K, Dwyer B. Molecular cloning of a highly repetitive DNA element from M. tuberculosis and its use as an epidemiological tool. J Clin Microbiol 1992;30:942-6.
11. Friedman CR, Stoeckle MY, Johnson WD, Riley LW. Double-repetitive element PCR method for subtyping Mycobacterium tuberculosis clinical isolates. J Clin Microbiol 1995;33:1383-4.
12. Grover AA, Kim HK, Wiegeshaus EH, Smith DW. Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70°C. J Bacteriol 1967;94: 832-5.
13. Smith PG, Morrow MG, eds. Methods for field trials of interventions against tropical diseases. A toolbox. Oxford, UK: Oxford University Press, 1991:289-94.
14. Lin RL, Bernard EM, Armstrong D, Chen CH, Riley LW. Transmission patterns of tuberculosis in Taiwan: analysis by restriction fragment length polymorphism. Int J Infect Dis 1996;1:18-21.
15. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-9.
16. Templeton GI, Braden CR, Investigative Team. The epidemiologic interpretation of DNA fingerprints of M. tuberculosis isolates in Arkansas. Am J Respir Crit Care Med 1995;151:A666.
17. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994;330:1710-6.
18. Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC. Tuberculosis in drug users. Clin Infect Dis 1995;21:1253-64.
19. Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med 1979;139: 337-9.
20. McAdam JM, Brickner PW, Scharer LL, Crocco JA, Duff AE. The spectrum of tuberculosis in New York City men's shelter clinic (1982-1988). Chest 1990;97:798-805.
21. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
22. Centers for Disease Control. Crack cocaine use among persons with tuberculosis: Contra Costa County, California, 1987-1990. MMWR 1991; 4:485-9.
23. Leonhardt KK, Gentile F, Gibert BP, Aiken M. A cluster of tuberculosis among crack house contacts in San Mateo County, California. Am J Public Health 1994;84:1834-6.
24. Graham NMH, Nelson KE, Solomon L, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and seronegative intravenous drug users. JAMA 1992;267:369-73.
25. Kreek MJ. Immune function in human IVDUs. In: Harris L, ed. Problems of drug dependence. In: Proceedings of the 45th annual meeting of the College on Problems of Drug Dependence, Inc. (1992). Research monograph 132. Rockville, Maryland: National Institute on Drug Abuse, 1993.
26. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
27. Lowenstein CJ, Dinerman JJL, Snyder SH. Nitric oxide: a physiologic messenger. Ann Intern Med 1994;120:227-37.
28. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:915-8.
29. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992;175:1111-22.
30. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J Exp Med 1993;178:2243-8.
31. Flesch I, Kaufmann SHE Mycobacterial growth inhibition by interferon-γ-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. J Immunol 1987;138: 4408-13.
32. Schneemann M, Shoendon G, Hofer S, et al. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 1993;167:1358-63.